Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/30/2026 | 37,832 | 0.1% | 49,014 | 12/31/2025 |
| 2025 Q3 | 10/31/2025 | 35,322 | 0.1% | 62,820 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 36,091 | 0.1% | 68,744 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 43,470 | 0.1% | 68,540 | 3/31/2025 |
| 2024 Q4 | 2/12/2025 | 50,325 | 0.1% | 70,648 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 80,235 | 0.2% | 76,324 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 81,905 | 0.2% | 77,928 | 6/30/2024 |
| 2024 Q1 | 5/10/2024 | 82,578 | 0.2% | 85,793 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 78,581 | 0.2% | 89,471 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 74,432 | 0.2% | 90,444 | 9/30/2023 |
| 2023 Q2 | 8/8/2023 | 98,140 | 0.2% | 136,582 | 6/30/2023 |
| 2023 Q1 | 5/10/2023 | 112,423 | 0.3% | 136,823 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 110,411 | 0.3% | 153,032 | 12/31/2022 |
| 2022 Q2 | 8/9/2022 | 114,870 | 0.3% | 194,324 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 129,644 | 0.3% | 185,625 | 3/31/2022 |
| 2021 Q4 | 2/9/2022 | 118,495 | 0.2% | 187,634 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 103,845 | 0.2% | 171,594 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 93,329 | 0.2% | 168,734 | 6/30/2021 |
| 2021 Q1 | 5/12/2021 | 82,880 | 0.2% | 173,941 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 67,333 | 0.1% | 139,373 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 70,763 | 0.2% | 126,414 | 9/30/2020 |
| 2020 Q2 | 9/11/2020 | 78,747 | 0.2% | 126,267 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 38,465 | 0.1% | 78,775 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 27,963 | 0.1% | 74,472 | 12/31/2019 |
| 2014 Q1 | 5/13/2014 | 44,008 | 0.1% | 146,557 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 39,532 | 0.1% | 143,626 | 12/31/2013 |